Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vascular Augmentation of Late-life Unremitted Depression
ISRCTN46911260Phase 3Completed
- Sponsor
- Gateshead Health NHS Foundation Trust
- Start
- Mar 2012
- Modality
- Small Molecules
01
Overview
Phase 3, randomised trial in major depressive disorder (MDD) and vascular depression (VD) comparing amlodipine augmentation with placebo augmentation (2 arms). Primary endpoint: response rates to study invitation. Started Mar 2012; status: completed.
02
Drugs
amlodipine
03
Conditions
major depressive disorder (MDD)vascular depression (VD)
Beyond the preview
Go deeper on ISRCTN46911260.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN46911260.